ARCHIVES

Rituximab and Fludarabine Combination Produces Long-Term Remissions in CLL

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Twenty-Nine Percent Of Approved Organ Systems Applications Funded In February, May Cycles

November 4, 1983

Longer Awards, Annual Recompetition considered For “CCOP 3;” Concept to DCPC Board In January

July 15, 1988

Funding opportunities listed.

September 24, 2004

Two Cooperative Groups Renamed ECOG-ACRIN

September 23, 2011

Clinical Research Group Of ACCC Meets

April 24, 1981

DCT Board Approves New RFA For Aids Clinical Trials Groups

November 11, 1994